The first patient has been implanted in a Defense Department-funded clinical trial evaluating Neuronoff’s Injectrode device for the treatment of neurogenic bladder in people with spinal cord injury.

Neuronoff, Inc., a clinical-stage neuromodulation company, today announced the first patient implant in a Department of ...

Dental implants are a safe and effective tooth replacement option with a strong clinical record. Understanding their benefits ...

Spinal cord injuries can have devastating consequences for those affected. Nerve cells in the spinal cord rarely regenerate ...

Vagus nerve stimulation devices have moved into the mainstream wellness market as more people look for ways to manage stress, ...

The company recommends using it before sleep, before or during meditation, after sport, between meetings or anytime stress or ...

Pulsetto Lite is currently listed at $278, and Pulsetto Fit is priced at $296 on the company's website. Both models deliver ...

Preliminary research turns to a fully implantable system ...

The company recommends using Pulsetto in moments built around relaxation: before sleep, during meditation and after exercise.

Outgoing Nyxoah CEO Olivier Taelman [Image from LinkedIn] Nyxoah announced today that it plans to move on from current CEO Olivier Taelman and begin a search for a new chief executive.

Researchers in Zurich say they have developed a method to use microrobots delivering stem cell therapies to treat spinal cord ...

Many influencers encourage wearable devices to stimulate this critical nerve fibers. But there's a difference between ...